The U.S. Food and Drug Administration (FDA) approved suzetrigine under the brand name Journavx on Jan. 30, 2025. Journavx is a first-in-class non-opioid painkiller that acts on sodium channels in the ...

Quoin Pharmaceuticals (QNRX) has launched the “NETHERTON NOW” campaign to shed light on the profound and poorly understood impacts of Netherton ...

Quoin Pharmaceuticals Ltd. (QNRX), a specialty pharmaceutical company currently valued at $2.42 million, announced today the initiation of the "NETHERTON NOW" campaign aimed at increasing awareness of ...

An update from Neuren Pharmaceuticals Limited ( ($AU:NEU) ) is now available. Neuren Pharmaceuticals announced the receipt of its one-third share ...

Supernus Pharmaceuticals' FDA approval for ONAPGO in Parkinson's Disease offers optimism despite past challenges, with a ...

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Vertex Pharmaceuticals wasn’t one of them. The 10 stocks that ...

UnitedHealth has reached out to the U.S. Securities and Exchange Commission about billionaire investor Bill Ackman's ...

D.C.’s Vanda Pharmaceuticals Inc. has locked in a deal with a West Coast biotech to commercialize a drug for a rare skin ...

I am hopeful for a trial decision by the end of the 1st quarter. So, why hold Finch stock now when we may not see a decision ...

The rise of counterfeit fentanyl-laced pharmaceuticals threatens public health. Innovative molecular analytical methods are ...

10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Shares of NASDAQ:SYRS opened at $0.18 on Friday. Syros Pharmaceuticals has a ...